C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2002
11/21/2002	WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors
11/21/2002	US20020173664 An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example
11/21/2002	US20020173659 Indole derivatives for the treatment of osteoporosis
11/21/2002	US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002	US20020173529 Fungicide active substance combinations
11/21/2002	US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002	US20020173526 Heterocyclic compounds their production and use
11/21/2002	US20020173512 Psychological disorders; antidepressants
11/21/2002	US20020173506 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
11/21/2002	US20020173492 Novel pesticides
11/21/2002	US20020173425 Herbicides
11/21/2002	DE10135549A1 New 4-heterocyclyl-1-benzyloxybenzene derivatives, useful as pesticides for plant protection and preservation of technical products, and as intermediates for active compounds
11/21/2002	CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002	CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/20/2002	EP1258484A1 Novel isoxazole and thiazole compounds and use thereof as drugs
11/20/2002	EP1258480A1 Pharmaceutical use of N-Carbamoylazole derivatives
11/20/2002	EP1257549A2 Matrix metalloproteinase inhibitors and uses thereof
11/20/2002	EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002	EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257543A1 Pyridinylimidazoles
11/20/2002	EP1187832B1 Amino heterocycles useful as pharmaceutical agents
11/20/2002	EP1165472A4 Methods for the preparation of biphenyl isoxazole sulfonamides
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	EP0925302B1 Palladium catalyzed indolization
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/19/2002	US6482958 Methods for the preparation of 4-hydroxy benzothiophene
11/19/2002	US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482946 High char yield benzoxazine compositions
11/19/2002	US6482842 3-aminopyrazole inhibitors of cyclin dependent kinases
11/19/2002	US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002	US6482774 Substituted (4-brompyrazole-3-yl) benzazoles
11/19/2002	US6482773 Pyridazin-3-one derivatives, their use, and intermediates for their production
11/18/2002	WO2001087855A1 Triazole derivatives
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002	WO2002089793A1 Sulfonamides
11/14/2002	WO2002089782A2 Dioxanes and uses thereof
11/14/2002	WO2002081453A8 Thiohydantoins and use thereof for treating diabetes
11/14/2002	WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002	WO2002068417A3 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/14/2002	WO2002055014A3 Therapeutic chroman compounds
11/14/2002	WO2002055013A3 Therapeutic chromone compounds
11/14/2002	WO2002055012A3 Therapeutic heterocyclic compounds
11/14/2002	WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002	US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002	US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
11/14/2002	US20020169312 Reacting N-aryl-O-alkylcarbamate with an amide derivative in the presence of a lithium cation, a base, and a nucleophile
11/14/2002	US20020169203 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
11/14/2002	US20020169191 Oxazolidinone compounds and methods of preparation and use thereof
11/14/2002	US20020169188 Modulating neurotransmission in the central nervous system
11/14/2002	US20020169180 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
11/14/2002	US20020169173 Administering to a patient an effective amount of oxazole derivative to treat cytokine mediated diseases
11/14/2002	US20020169165 Substituted bicyclic derivatives for the treatment of abnormal cell growth
11/14/2002	US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002	CA2446396A1 N-aroyl cyclic amines
11/14/2002	CA2446120A1 Novel arylheteroalkylamine derivatives
11/13/2002	EP1255754A1 Linezolid-crystal form ii
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255743A1 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa
11/13/2002	EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP1140916B1 Heteroaryl-cyclic acetals
11/13/2002	EP1102762B1 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
11/13/2002	EP0891340B1 Oxazole derivatives, their production and use
11/13/2002	EP0843672B1 One pot synthesis of 2-oxazolidinone derivatives
11/13/2002	EP0748320B1 Prodrugs of morpholine tachykinin receptor antagonists
11/13/2002	CN1379775A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/13/2002	CN1379774A Compounds
11/13/2002	CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/12/2002	US6479529 Antioxidant stabilizer system for pharmaceutical formulations
11/12/2002	US6479514 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
11/12/2002	US6479508 Viral polymerase inhibitors
11/12/2002	US6479494 Arylalkanoyl pyridazines
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479491 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
11/12/2002	US6479483 3,4,6-substituted pyridine derivatives useful for treating depression and pain, resulting from inflammatory conditions, such as migraine, rheumatoid arthritis, asthma and inflamatory bowel disease; nk1 receptor antagonist
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/07/2002	WO2002088116A1 Coumarin derivative
11/07/2002	WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002	WO2002088113A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088112A1 Heterocyclic compound and antitumor agent containing the same as active ingredient
11/07/2002	WO2002088111A1 Novel benzylpiperidine compound
11/07/2002	WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002	WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088087A1 Novel heterocyclic derivatives
11/07/2002	WO2002087619A1 Preventive/therapeutic method for cancer
11/07/2002	WO2002087618A1 Preventive/therapeutic method for cancer

1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 647